Medpace Holdings, Inc.
MEDP
株式のランク
#1302
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
株価
$622.03
最終同期: 2026-10-20
時価総額
$17.36B
変化（1日）
0.38%
変化（1年）
14.00%
国
US
取引 Medpace Holdings, Inc. (MEDP)
カテゴリー
Healthcare
Medpace Holdings, Inc.（MEDP）の発行済株式数
June 2026 時点の発行済株式数 28.31M
Medpace Holdings, Inc. の最新の財務報告および株価によると、現在の発行済株式数は 28.31M です。December 2024 の終わりには、同社は 30.96M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Medpace Holdings, Inc.（MEDP）の発行済株式数の履歴（2013 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 28.31M | -1.87% |
| 2025 | 28.85M | -6.82% |
| 2024 | 30.96M | 0.76% |
| 2023 | 30.72M | -5.14% |
| 2022 | 32.39M | -9.69% |
| 2021 | 35.86M | 0.64% |
| 2020 | 35.64M | -0.69% |
| 2019 | 35.88M | 0.94% |
| 2018 | 35.55M | -8.98% |
| 2017 | 39.06M | 9.43% |
| 2016 | 35.69M | -9.94% |
| 2015 | 39.63M | 34.65% |
| 2014 | 29.43M | -23.24% |
| 2013 | 38.35M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 371.00M | 1,210.58% |
US
|
|
| 705.30M | 2,391.52% |
US
|
|
| 143.28M | 406.14% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 896.18% |
US
|
